PDCD1 and hepatocellular carcinoma: HCC DNA methylation profiles are highly enriched in immune functions including genes such as Programmed cell Death 1 (PD-1), a negative regulator of T cell immune response that is an important target in current cancer immunotherapy [43] and show no significant overlap with the DNA methylation profiles of previously described HCC tumors [23].